Industry News
CSL Behring announces completion of national marketing authorizations of Berinert® after MRP in 23 European countries
CSL Behring announced today it has been granted national marketing authorization in Italy and Luxembourg to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. This latest authorization brings to 28…
CSL Behring Announces Locations and Host Partners for its 9th Annual Gettin’ in the GameSM Junior National Championship
CSL Behring announced today the schedule for its 9th annual Gettin’ in the GameSM Junior National Championship (JNC) competition in golf and baseball. The JNC is a series of one-day athletic events for children with bleeding disorders, such as hemoph…
CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Relief Effort in Haiti
Direct Relief International announced today that CSL Behring has donated life-saving medicines valued at more than $100,000 to assist earthquake victims in Haiti who are at risk of tetanus or hepatitis B infections. The products will be used in clinics…
Young Women Urged to Recognize Symptoms of Widely Undiagnosed Bleeding Disorder
To promote the importance of screening young women for von Willebrand disease (VWD), the American Academy of Nurse Practitioners (AANP) today announced the launch of its VWD Young Women’s Education Campaign. Sponsored by CSL Behring, this educational…
CSL Behring Launches 2 New Programs this month for Patients & Caregivers
1. FactorPlus: This is a new free product trial program for Helixate FS.
Some of the highlights of the program:
Shipment of trial product directly to patients homes (physician can choose where product should go to i.e. HTC or patients home)
Inclusion of ancillary supplies with every shipment
A welcome kit with helpful …
TODAY GRIFOLS INTRODUCES MIX2VIAL FILTER TRANSFER SETS
Los Angeles, California (April 23, 2010). Grifols USA, LLC (Grifols) today announced the availability of the Mix2Vial™ transer set for the reconstitution and administratioon of Grifols’ coagulation therapies. TheMix2Vial™ is a plastic, needle-free transfer device with a built-in 15 micron filter specifically designed to be used with the Sterile Water …
CSL Behring Receives FDA Approval to Extend Shelf Life for Privigen® from 24 to 36 Months
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life for Privigen®, Immune Globulin Intravenous (Human), 10% Liquid, from 24 to 36 months…
CSL Behring Marks World Hemophilia Day with Factor IX Donation to World Federation of Hemophilia
Hemophilia B patients in the developing world will benefit from a recent donation of 1 million international units (IU) of factor IX medication made by CSL Behring to the World Federation of Hemophilia (WFH). The donation, channeled through WFH’s Uni…
New Survey Reveals That Parents Lack Information About Dehydration and Its Treatment
TachoSil indicated for use as an adjunct to hemostasis in cardiovascular surgery
CSL Behring Seeking Proposals for LEAD Grants to Support Patient Advocacy Efforts
CSL Behring, a global leader in the plasma protein biotherapeutics industry, is calling for grant requests through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program awards funds to United States patient organizations that…
